SynBiotic SE
SynBiotic SENuWays RecommendationRecommendation
Buy
Price Target
€12.40
Upside
232.44%
Chart
- 1M
- 3M
- 6M
- YTD
- 1Y
- 3Y
€3.73
€0.20 (5.52%)
Realtime-Data from 30.04.2025 20:53:18
SYNBIOTIC is a Buy-and-Build operator in the European industrial hemp, cannabis and cannabinoid market with an objective to establish a fully integrated platform-company with activities across the entire value chain from cultivation to production and retail.
Ticker
SBX GY
Market Cap
€20.89 M
Enterprise Value
€23.96 M
26 week avg vol.
13500
Primar Exchange
Xetra
IPO
2019
Sector
Health Care & Pharma
Headquarters
München, DE
Employees
55
Incorporated
2015
CEO
Daniel Kruse
Website
CEO
7.62%
Other institutional investors
47.00%
Free Float
45.38%
20.09.2024
Annual General Meeting
30.09.2024
Publication half yearly financial report
KPIs in EUR
| KPI | 2023 | 2024e | 2025e |
|---|---|---|---|
| Sales | 3.86 M | 15.92 M | 22.99 M |
| EBITDA | (7.19 M) | (1.01 M) | 1.84 M |
| EBIT | (11.75 M) | (2.13 M) | 756.62 K |
| EPS | (2.12) | (0.30) | 0.06 |
| FCF | (2.94 M) | (4.33 M) | 1.35 M |
Valuation
| KPI | 2023 | 2024e | 2025e |
|---|---|---|---|
| EV / Sales | 6.20x | 1.49x | 0.97x |
| EV / EBITDA | (3.33x) | (23.36x) | 12.17x |
| EV / EBIT | (2.04x) | (11.13x) | 29.52x |
| Price / Earnings | (1.76x) | (12.25x) | 61.75x |
| EV / FCF | (8.14x) | (5.47x) | 16.51x |
Downloads
Latest Research
Initiation